ISS recommends Aptose shareholders vote FOR Hanmi arrangement at C$2.41/share

Aptose Biosciences Inc.

ISS recommends voting FOR the arrangement with Hanmi Pharmaceutical and the continuance to ABCA.
Shareholders to receive C$2.41 per share cash, a 28% premium over the 30-day VWAP of C$1.88.
Special meeting reconvened to March 31, 2026; proxy deadline is March 27, 2026 at 11:00 AM ET.
Board of directors unanimously recommends approval of the arrangement resolution.
Completion subject to court approval, TSX approval, and other customary conditions.

item 7.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.